Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG Block and Intrathecal Morphine in Anterior Hip Arthroplasty
NCT06298370Recruiting
- Sponsor
- Bezmialem Vakif University
- Start
- Mar 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of morphine and bupivacaine hydrochloride 0.75% injection in postoperative pain (3 arms), sponsored by Bezmialem Vakif University. Primary endpoint: Morphine consumption at 48 hours. Started Mar 2024; status: recruiting.
02
Drugs
morphinebupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06298370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06298370.